Ryzumvi Eye Drop Wins FDA Approval for Presbyopia, with 27% Reaching the Main Goal in Its Larger Trial

The FDA approved Ryzumvi eye drops for presbyopia in adults. See how the nightly drop works, trial results, side effects, and what remains unknown.
This is a short summary. The full story is published by Inkl.
Read full story at Inkl
